NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
Alicia Solorzano
Pfizer Inc. - New York / United States
Others
AD Scientific Index ID: 4390637
-
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Pfizer Inc.
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
Alicia Solorzano's MOST POPULAR ARTICLES
1-)
A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission Science 315 (5812), 655-659, 2007
2-)
Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality … Journal of virology 79 (23), 14933-14944, 2005
3-)
Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs Journal of virology 79 (12), 7535-7543, 2005
4-)
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial Nature medicine 27 (1), 106-114, 2021
5-)
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trialR Nachbagauer, J Feser, A Naficy, DI Bernstein, J Guptill, EB Walter, ...Nature medicine 27 (1), 106-114, 20213022021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept